Medline Inc. (MDLN) — Institutional Holders, Q2 2026 (page 5)

413 institutional investment managers reported a MDLN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $33.6B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 401 to 413. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

MDLN 13F holders ranked 401–413 of 413

Institutional investors reporting a position in Medline Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Activest Wealth Management#401 · 9 sh$355.00+350.0%
Clearstead Advisors#402 · 9 sh$355.00New
WEST PACES ADVISORS#403 · 7 sh$276.00New
Strive Financial Group#404 · 7 sh$276.00New
James T. Borello RIA#405 · 7 sh$276.00-94.7%
MV CAPITAL MANAGEMENT#406 · 6 sh$237.00+200.0%
Essential Partners#407 · 4 sh$158.00New
Cordant#408 · 4 sh$152.00New
Davis Capital Management#409 · 1 sh$39.00New
Highland Investment Advisors#410 · 1 sh$39.00—
Pacer Advisors#411 · 10 sh$0.00New
Erste Asset Management GmbH#412 · 0 sh$0.00New
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#413 · 579,968 sh—+3163.9%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.